Aurora Cannabis

Aurora Cannabis

Aurora Cannabis was established in 2013 by Terry Booth, a former construction and oil-and-gas entrepreneur, as medical cannabis regulations in Canada began permitting large-scale licensed producers. The company went public in 2016 via a reverse takeover and subsequently pursued an aggressive acquisition strategy, absorbing rival producers including MedReleaf, CanniMed Therapeutics, and ICC Labs across Canada, Denmark, and Latin America. That consolidation made Aurora the largest cultivator by funded capacity ahead of Canada's October 2018 recreational legalization, though the equity-funded buying spree left a complex international footprint that later required significant restructuring. The company's deployment now concentrates on three pillars: Canadian adult-use brands such as San Rafael '71 and Daily Special, international medical cannabis exports — chiefly to the European Union and Australia — and a nascent domestic medical business. Aurora has largely exited direct cultivation in Europe and South America, choosing instead to supply those markets from its Aurora Sky facility at Edmonton International Airport, a purpose-built hybrid greenhouse. The group's pharmaceutical ambitions also include a minority stake in Radient Technologies, a extraction-services provider, and a long-standing clinical-research agreement with the Ultimate Fighting Championship to study CBD's effects on athlete recovery. In 2023 Aurora acquired a controlling interest in Bevo Farms, a large-scale vegetable and flower propagation business, using the subsidiary's agri-engineering capabilities to lower per-unit growing costs across its cannabis operations. Headcount has contracted materially from a 2019 peak, when the firm employed over 2,700 people; the current workforce is materially smaller following the closure of legacy sites in Alberta, Saskatchewan, and Quebec. Miguel Martin, a former executive at tobacco company Altria and beverage firm Pabst Brewing, succeeded Booth as CEO in September 2020 and has led the rationalization effort. February 2024: Aurora completed a 1-for-10 reverse share split to regain NASDAQ compliance (per the firm, February 2024), consolidating its listed equity after sustained pressure on its share price. Aurora's real structural differentiator is the Bevo Farms acquisition — a profitable, non-cannabis operating subsidiary that provides propagation services to greenhouse vegetable growers across North America. That unusual asset gives Aurora a cash-flow cushion and technical expertise unmatched by any other Canadian licensed producer, effectively creating a dual-track business model where a traditional agri-services division underwrites the volatility of the regulated cannabis market. The arrangement also opens a potential succession path if the firm's medical and consumer strategies alone prove insufficient to reach profitability.